Markets Weigh Fed Signals, Chips Soar, Bears Prowl Biotech

Macro: Fed Stays Cautious

Fed Governor Barkin said today that consumers have kept spending, backed by solid employment. He added that high uncertainty has become the new baseline for business leaders. That framing suggests the Fed is in no hurry to cut rates. Investments are broadening beyond data centres, he noted — a rare positive signal for broader capital spending.

US: Chips Lead, Biotech Bears Circle

Memory semiconductors remain the hottest trade. Micron Technology and Sandisk are attracting the heaviest bullish options flow this week, riding an AI-driven demand wave. NVIDIA also draws consistent call buying.

On the short side, bears are piling into biotech. Replimune saw short interest jump nearly 11 percentage points in a week to 43.3% of free float, even as shares sit 188% higher over three months. Tango Therapeutics sits at 64.5% — shorts keep building despite little price movement. AppLovin faces heavy put flow after crashing 53% year-to-date. Its RSI has dropped to 28, yet traders are still hedging further downside ahead of earnings.

Illumina drew attention after a board-level director filed $148M in share sales. Aptiv offered the contrarian signal — both a director and the CEO bought shares in back-to-back transactions totalling $7.5M.

Europe: Hugo Boss Tests Recovery

In Europe, Hugo Boss presents Q2 results today. The luxury fashion brand has struggled with slowing consumer demand. The update will reveal whether a recovery is taking hold across European discretionary names.

On the analyst front, AbbVie earned a notable upgrade, now carrying 24 Buy ratings. SM Energy was upgraded to Overweight by Wells Fargo with a new $47 target.